-
Lacayo, NJ, Pullarkat, VA, Stock, W, Jabbour, E, Bajel, A, Rubnitz, J, Leonard, J, Mullighan, CG, Khaw, SL, Vear, SI, et al.
Safety and Efficacy of Venetoclax in Combination with Navitoclax in Adult and Pediatric Relapsed/Refractory Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma.
Blood
134(Supplement_1)
:
285
2019
view publication
-
Brown, LM, Bartolo, RC, Davidson, NM, Schmidt, B, Brooks, I, Challis, J, Petrovic, V, Khuong-Quang, D-A, Mechinaud, F, Khaw, SL, et al.
Targeted therapy and disease monitoring in CNTRL-FGFR1-driven leukaemia..
Pediatr Blood Cancer
66(10)
:
e27897
2019
view publication
-
Meyer, C, Lopes, BA, Caye-Eude, A, Cavé, H, Arfeuille, C, Cuccuini, W, Sutton, R, Venn, NC, Oh, SH, Tsaur, G, et al.
Human MLL/KMT2A gene exhibits a second breakpoint cluster region for recurrent MLL-USP2 fusions..
Leukemia
33(9)
:
2306 -2340
2019
view publication
-
Jabbour, E, Mullighan, CG, Pullarkat, VA, Lacayo, NJ, Bajel, A, Rubnitz, J, Leonard, J, Khaw, SL, Vear, SI, Alexander, T, et al.
Combination BCL-2 Inhibitor Therapy with Venetoclax and Navitoclax in Patients with Relapsed/Refractory Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma.
Clinical Lymphoma Myeloma & Leukemia
19:
s184 -s185
2019
view publication
-
Moujalled, D, Hanna, D, Pomillio, G, Litalien, V, Fleming, S, Chanrion, M, Maragno, A-L, Kraus-Berthier, L, Khaw, S, Lessene, G, et al.
IDENTIFICATION OF POTENT BH3-MIMETIC COMBINATIONS TARGETING PRO-SURVIVAL PATHWAYS IN HUMAN B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA.
Experimental Hematology
76:
s79 -s80
2019
view publication